<DOC>
	<DOCNO>NCT01623882</DOCNO>
	<brief_summary>The primary purpose study evaluate safety efficacy concurrent use Apligraf速 SNaP速 Wound Care System treatment diabetic venous stasis lower extremity ulcer .</brief_summary>
	<brief_title>Clinical Evaluation Combined Use Apligraf速 SNaP速 Pressure Wound Therapy System</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Wound &lt; 10 cm great diameter Wound age &gt; 4 week patient show &lt; 50 % wound area heal 4 week treatment Patient &gt; 18 year age Patient willing able sign consent Patient willing able complete study visit comply study dressing protocol Wound size reduction &gt; 50 % last 4 week treatment Patients active wound infection , include cellulitis osteomyelitis Patients wound able eschar debrided ABI &lt; 0.65 SPP &lt; 30mmHg Patients wound anatomic area preclude achieve airtight seal NPWT Ulcers due inflammatory condition rheumatoid arthritis , lupus , scleroderma , vasculitis , calciphylaxis , etc . Patients allergy intolerance wind dress material expect used trial . Pregnant patient Patients unable tolerate NPWT Patients dialysis dependent ESRD Index ulcer plantar surface foot</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Wounds</keyword>
	<keyword>Ulcers</keyword>
</DOC>